HCA Holdings (HCA) PT Lowered to $88 at Jefferies; Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Credit Suisse Assumes HCA Holdings (HCA) at Outperform
November 3, 2017 2:26 AM EDTCredit Suisse assumes coverage on HCA Holdings (NYSE: HCA) with a Outperform rating and a price target of $95.00.
For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.
Shares of HCA Holdings closed at $76.43 yesterday.
... MoreHCA Holdings (HCA) PT Lowered to $82 at Piper Jaffray Following 3Q
November 1, 2017 9:04 AM EDTPiper Jaffray lowered its price target on HCA Holdings (NYSE: HCA) to $82.00 (from $86.00) while maintaining a Overweight rating following the company's 3Q earnings report. HCA reported 3Q17 results in-line with the disappointing preannouncement driven by the strong hurricane season, weaker volumes and higher expense... More
HCA Holdings (HCA) PT Lowered to $79 at Morgan Stanley
November 1, 2017 8:55 AM EDTMorgan Stanley lowered its price target on HCA Holdings (NYSE: HCA) to $79.00 (from $85.00) while maintaining a Equalweight rating.
... MoreHCA Holdings (HCA) Misses Q3 EPS by 72c, Miss on Revenues; FY17 EPS Outlook Below Consensus
October 31, 2017 8:33 AM EDTHCA Holdings (NYSE: HCA) reported Q3 EPS of $1.21, $0.72 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $11.13 billion.
Key third quarter metrics (all percentage changes compare 3Q 2017 to 3Q 2016 unless noted):
Revenues increased 4.2 percent to $10.696 billionNet income attributable to HCA Healthcare, Inc. totaled $426 million, or $1.15 per diluted shareAdjusted EBITDA totaled... More